| Expression pattern: |
UP |
| Associated gene: |
FOXM1 |
| Associated microRNA: |
miR-485-5p |
| Biological function: |
Promotes dedifferentiated thyroid cancer cell proliferation, cell-cycle progression, glycolysis, and tumor growth in vivo. |
| Molecular mechanism: |
hsa_circ_0023990 functions as a miRNA sponge for miR-485-5p, thereby upregulating FOXM1 expression and promoting proliferation and glycolysis. |
| Biological pathway or process: |
proliferation (promotes); cell cycle (promotes); glycolysis (promotes); ceRNA regulation (promotes); other pathway/process (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Luciferase Reporter Assay; Bioinformatics Analysis; Transfection; CCK8; Colony Formation Assay; EdU Staining; Cell Cycle Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); H&E Staining |
| Clinical significance: |
hsa_circ_0023990 might be a potential therapeutic target for dedifferentiated thyroid cancer treatment. |
| Description: |
hsa_circ_0023990 is upregulated in thyroid cancer, especially dedifferentiated thyroid cancer tissues and cell lines. It promotes proliferation, cell-cycle progression, glycolysis, and xenograft tumor growth by sponging miR-485-5p and increasing FOXM1 expression. The study suggests hsa_circ_0023990 as a potential therapeutic target for dedifferentiated thyroid cancer. |
| Confidence score: |
0.7375 |